The University of Cincinnati ;The General Hospital Corporation ;The United States of America, as represented by the Secretary, Department of Health & Human Servic
发明人:
Hajjar Roger J.,del Monte Federica,Kranias Evangelia
申请号：
US201615065507
公开号：
US2018296578(A1)
申请日:
2016.03.09
申请国别(地区):
美国
年份:
2018
代理人:
摘要：
Expression of a phosphatase inhibitor in heart cells can be used to treat cardiac disorders, e.g., heart failure. Decreasing phosphatase activity can improve β-adrenergic responsiveness.
